Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4850575
Max Phase: Preclinical
Molecular Formula: C37H55N11O10
Molecular Weight: 813.91
Molecule Type: Unknown
Associated Items:
ID: ALA4850575
Max Phase: Preclinical
Molecular Formula: C37H55N11O10
Molecular Weight: 813.91
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1NC(=O)[C@H]([C@H](C)O)NC(=O)[C@@H](NC(=O)OCc2ccccc2)CCCCNC(=N)NCCC[C@H](C(=O)N[C@@H](CCCCNC(=O)c2cnco2)C(N)=O)NC1=O
Standard InChI: InChI=1S/C37H55N11O10/c1-22-31(51)46-26(32(52)45-25(30(38)50)13-6-8-16-41-34(54)28-19-40-21-58-28)15-10-18-43-36(39)42-17-9-7-14-27(33(53)48-29(23(2)49)35(55)44-22)47-37(56)57-20-24-11-4-3-5-12-24/h3-5,11-12,19,21-23,25-27,29,49H,6-10,13-18,20H2,1-2H3,(H2,38,50)(H,41,54)(H,44,55)(H,45,52)(H,46,51)(H,47,56)(H,48,53)(H3,39,42,43)/t22-,23-,25-,26+,27-,29-/m0/s1
Standard InChI Key: VFXVWVOWASHEBB-XKDOBVCESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 813.91 | Molecular Weight (Monoisotopic): 813.4133 | AlogP: -1.23 | #Rotatable Bonds: 13 |
Polar Surface Area: 321.09 | Molecular Species: BASE | HBA: 12 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.57 | CX Basic pKa: 12.00 | CX LogP: -3.37 | CX LogD: -5.14 |
Aromatic Rings: 2 | Heavy Atoms: 58 | QED Weighted: 0.11 | Np Likeness Score: 0.38 |
1. Jiang Y, Liu S, Tian G, Cheung HJH, Li X, Li XD.. (2021) Concise solid-phase synthesis enables derivatisation of YEATS domain cyclopeptide inhibitors for improved cellular uptake., 45 [PMID:34364221] [10.1016/j.bmc.2021.116342] |
Source(1):